Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 safety and pharmacokinetics study of RO7795081
NL-OMON58884Phase 1Completed
- Sponsor
- Roche
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of RO7795081 in type 2 diabetes mellitus (T2DM) and obesity, sponsored by Roche. Started Nov 2025; status: completed.
02
Drugs
RO7795081
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NL-OMON58884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58884.